Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740512
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)Polaryx Therapeutics, Inc.Not Yet RecruitingPhase 2
NCT07740512Not Yet Recruiting
Phase 2
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in P...Polaryx Therapeutics, Inc...
NCT07738224
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Research InstituteNot Yet RecruitingNot Applicable
NCT07738224Not Yet Recruiting
Not Applicable
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Researc...
NCT07738133
Mechanisms Underlying Late-Life Prolonged Grief DisorderMedical College of WisconsinNot Yet RecruitingNot Applicable
NCT07738133Not Yet Recruiting
Not Applicable
Mechanisms Underlying Late-Life Prolonged Grief DisorderMedical College of Wiscon...
NCT07739719
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)McMaster UniversityNot Yet RecruitingPhase 4
NCT07739719Not Yet Recruiting
Phase 4
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluste...McMaster University
NCT07738497
Biomarkers and Pharmacogenomics for Precision Depression TherapyThe Fourth Affiliated Hospital of Zhejiang University School of MedicineNot Yet RecruitingNot Applicable
NCT07738497Not Yet Recruiting
Not Applicable
Biomarkers and Pharmacogenomics for Precision Depression TherapyThe Fourth Affiliated Hos...
NCT07738822
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHACullinan Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07738822Not Yet Recruiting
Phase 1
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wA...Cullinan Therapeutics Inc...
NCT07740499
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel DiseaseIRCCS San RaffaeleNot Yet Recruiting
NCT07740499Not Yet Recruiting
—
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammator...IRCCS San Raffaele
NCT07738744
A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated With Liver and Digestive HealthCitruslabsCompletedNot Applicable
NCT07738744Completed
Not Applicable
A Clinical Trial to Evaluate the Effects of a Supplement on Symptoms Associated...Citruslabs
NCT07738796
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associated Acute Kidney Injury Based on the Gut-Kidney Axis, Incorporating Gut Microbiota and Their MetabolitesPeking Union Medical College HospitalNot Yet Recruiting
NCT07738796Not Yet Recruiting
—
Development and Validation of a Risk Prediction Model for Cardiac Surgery-associ...Peking Union Medical Coll...
NCT07739290
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney InjuryBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07739290Not Yet Recruiting
Not Applicable
NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute...Beth Israel Deaconess Med...
NCT07739043
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLCNot Yet RecruitingEarly Phase 1
NCT07739043Not Yet Recruiting
Early Phase 1
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLC
NCT07739303
Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Diaphragmatic Function in Shoulder SurgeryAnkara Etlik City HospitalNot Yet RecruitingNot Applicable
NCT07739303Not Yet Recruiting
Not Applicable
Anterior Suprascapular and Axillary vs. Interscalene Block for Analgesia and Dia...Ankara Etlik City Hospita...
NCT07739199
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739199Not Yet Recruiting
Phase 2
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Ver...Baili-Bio (Chengdu) Pharm...
NCT07738276
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityShahid Beheshti University of Medical SciencesNot Yet RecruitingPhase 3
NCT07738276Not Yet Recruiting
Phase 3
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist,...Shahid Beheshti Universit...
NCT07740018
Factors Affecting Clinical and Radiological Outcome in Endovascular Management of Acute Ischemic Stroke Due to Large Vessel OcclusionSohag UniversityRecruitingNot Applicable
NCT07740018Recruiting
Not Applicable
Factors Affecting Clinical and Radiological Outcome in Endovascular Management o...Sohag University
NCT07738653
Changes in Spatiotemporal Gait Parameters in Experienced MeditatorsFundacion PodoactivaCompletedNot Applicable
NCT07738653Completed
Not Applicable
Changes in Spatiotemporal Gait Parameters in Experienced MeditatorsFundacion Podoactiva
NCT07740395
Connecting Loved Ones to Support and Empowering RecoveryRhode Island HospitalRecruitingNot Applicable
NCT07740395Recruiting
Not Applicable
Connecting Loved Ones to Support and Empowering RecoveryRhode Island Hospital
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07738965
Mind-Body Pilates vs Pressure Biofeedback for Chronic Non-Specific Low Back PainLahore University of Biological and Applied SciencesNot Yet RecruitingNot Applicable
NCT07738965Not Yet Recruiting
Not Applicable
Mind-Body Pilates vs Pressure Biofeedback for Chronic Non-Specific Low Back PainLahore University of Biol...
Result Breakdown
Not yet recruiting14 (70%)
Completed4 (20%)
Recruiting2 (10%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 22 (10%)
Phase 41 (5%)
Phase 11 (5%)
Early Phase 11 (5%)
Phase 31 (5%)